ClinConnect ClinConnect Logo
Search / Trial NCT06789991

Electromyographic Activity of Posterior Oblique Sling Muscles in Patients With Shoulder Impingement Syndrome

Launched by CAIRO UNIVERSITY · Jan 22, 2025

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how certain muscles in the body work in patients who have shoulder impingement syndrome, a condition that causes pain and discomfort in the shoulder. Specifically, the researchers will look at the activity of two muscles: the gluteus maximus (found in the buttocks) and the latissimus dorsi (located in the back). By understanding how these muscles function, the aim is to improve rehabilitation programs and assessments for people suffering from this condition.

To participate in the trial, individuals must be between 25 and 40 years old and experiencing shoulder pain for at least three months. They should have a specific type of shoulder pain that can be confirmed through tests. However, those with certain conditions, like previous shoulder injuries, recent lower limb injuries, or specific skin issues, may not be eligible. Participants will engage in assessments that help researchers learn more about their muscle activity, ultimately contributing to better treatment options for shoulder impingement syndrome.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Both male and female patients with shoulder impingement syndrome.
  • 2. patients complain from unilateral shoulder pain with chronic conditions of SIS ≥ 3 months.
  • 3. Patient age from 25 to 40 years.
  • 4. Patients with Positive impingement tests.
  • 5. Patients with painful arc of movement (60°- 120°)
  • Exclusion Criteria:
  • 1. Patients with Numbness or tingling of upper extremity.
  • 2. Patients with Shoulder fracture or previous shoulder surgery, and Acromioclavicular or shoulder dislocation.
  • 3. Patients with Any traumatic injury to the lower limb in the previous 6 months.
  • 4. Any spine surgery within the last 2 years.
  • 5. Patients with history of lower back pain in past 12 months .
  • 6. Patients with history of lower extremity dysfunctions in the past 12 months .
  • 7. Participants who had taken any drugs (e.g. statins and spasmed), which have effects on the skeletal muscles.
  • 8. Open wounds, rashes, psoriasis, skin irritations, or skin conditions of any kind in the region of electrode placement
  • 9. Participants with a Body Mass Index (BMI) ≥ 30

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, Giza, Egypt

Patients applied

0 patients applied

Trial Officials

Soheir S Rizk, PhD

Study Chair

Cairo University

Aya A Khalil, PhD

Study Director

Cairo University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported